James R Maynard

Title: Innovations and Contributions of James R. Maynard

Introduction

James R. Maynard is a notable inventor based in Miami, Florida, recognized for his significant contributions to the field of medical diagnostics. With a total of four patents to his name, Maynard has developed innovative solutions that enhance the accuracy and efficiency of blood coagulation testing.

Latest Patents

One of Maynard's latest patents is the "Immunoassay for F1.2 prothrombin fragment." This invention focuses on generating highly specific-low affinity antibodies that allow for the assay of F1.2 in bodily fluids containing prothrombin or other plasma proteins. The antibodies are created using synthetic polypeptides that mimic the carboxy terminus of F1.2. Another significant patent is for "Extraction methods for preparing thromboplastin reagents." This invention describes the use of barium sulfate, chaotropic agents, and nonionic detergents for extracting sensitive thromboplastin reagents from tissue. The method enhances thromboplastin sensitivity, which is crucial for Prothrombin Time (PT) tests used in monitoring blood coagulation.

Career Highlights

Throughout his career, James R. Maynard has worked with prominent companies in the medical diagnostics industry, including Baxter Diagnostics Inc. and Dade Behring Inc. His work has significantly impacted the development of diagnostic tools that are essential for patient care.

Collaborations

Maynard has collaborated with several professionals in his field, including Pamela L. Hawkins and Juan A. Ruiz. These collaborations have contributed to the advancement of his inventions and the overall progress in medical diagnostics.

Conclusion

James R. Maynard's innovative patents and career achievements highlight his important role in the field of medical diagnostics. His contributions continue to influence the accuracy of blood coagulation testing and improve patient outcomes.